RE:Algernon treatmentNP-120 has been recognized mostly in Asia, South Korea mainly because of the Bird Flu attacked mostly that part of the Earth. Not too many cases in America that is why they want a certain assurance.
When you read the NR, you understand that HC and FDA are asking for a MINIMUM of proven data, they are not asking the full Pre-Clinicals trials, Phase 1, ETC...
I share the same opinion. But it is what it is. Go read the about the similarities of the Bird Flu and the Covid19, similar symptoms.
They have to take this case seriously, they can't skip a step which could have such an impact on the lives millions of people. I understand the frustration, many of us share the same view.
There is no incompetence here, AGN has done everything right in my opinion, they have to adjust and respond to different Gov. bodies that require different measures.
Undervalued, huge potential. There is risk, like with any company.
Good news that two treatments failed last week. This week will bring more and more exposure.
David